A. Macgowan et al., EXTERNAL QUALITY ASSESSMENT OF THE SERUM BACTERICIDAL TEST - RESULTS OF A METHODOLOGY INTERPRETATION QUESTIONNAIRE/, Journal of antimicrobial chemotherapy, 39(2), 1997, pp. 277-284
Two hundred microbiology laboratories in the UK took part in two separ
ate experimental external quality assessment distributions related to
the serum bactericidal test (SET). In the first, Staphylococcus aureus
NCTC 6571 (vancomycin MIC 1 mg/L), was tested against a human serum c
ontaining vancomycin 38 mg/L plus gentamicin 0.5 mg/L. In the second,
Streptococcus oralis PAJ 112/4183 (penicillin MBC less than or equal t
o 0.03 mg/L) and Streptococcus sanguis PAJ 107/4184 (penicillin MBC =
128 mg/L) were tested against human serum containing penicillin 15 mg/
L. Respondents returned their laboratory results and a questionnaire o
n clinical interpretation and technical aspects. Most laboratories (19
4/199, 97.5%) recommend the use of the SET in the management of infect
ive endocarditis but only 48 (25.2%) often or always change therapy on
the basis of the result. A wide range of interpretative criteria, def
initions of bactericidal endpoints and methodologies are used. Perform
ance in the first distribution was acceptable for 75% of laboratories
but in the second only 34% could identify penicillin tolerance; 34 res
pondents reported an SET result of less than or equal to 2 for the tol
erant strain, 81 laboratories reported one of greater than or equal to
16. Technical factors related to acceptable performance were: sonicat
ion of broth before counting the inoculum; knowing the inoculum size i
n cfu/mL; use of a 4-8 h broth culture to make the inoculum; incubatio
n of recovery plates for >36 h; use of a calibrated pipette to sample
for surviving bacteria; use of measured volumes to add the inoculum. U
se of uncalibrated pipettes or standard loops to recover survivors was
related to poor performance. Microbiology departments in the UK shoul
d review the clinical need to perform the SET in the light of their lo
cal circumstances and if they elect to continue to offer this test, re
vise their methodologies which could be producing misleading results w
hen testing alpha-haemolytic streptococci.